wide association studies (GWAS) promised to translate their findings into 31 clinically beneficial improvements of patient management by tailoring disease 32 management to the individual through the prediction of disease risk 1,2 . However, the 33 ability to translate genetic findings from GWAS into predictive tools that are of clinical 34 utility and which may inform clinical practice has, so far, been encouraging but 35 limited 1,2 . Here we propose to use a more powerful statistical approach that enables the 36 prediction of multiple medically relevant phenotypes without the costs associated with 37 developing a genetic test for each of them. As a proof of principle, we used a common 38 panel of 319,038 SNPs to train the prediction models in 114,264 unrelated White-British 39 for height and four obesity related traits (body mass index, basal metabolic rate, body 40 fat percentage, and waist-to-hip ratio). We obtained prediction accuracies that ranged 41 between 46% and 75% of the maximum achievable given their explained heritable 42 component. This represents an improvement of up to 75% over the phenotypic variance 43 explained by the predictors developed through large collaborations 3 , which used more 44 than twice as many training samples. Across-population predictions in White non-45 British individuals were similar to those of White-British whilst those in Asian and Black 46 individuals were informative but less accurate. The genotyping of circa 500,000 UK 47
Biobank 4 participants will yield predictions ranging between 66% and 83% of the 48 maximum. We anticipate that our models and a common panel of genetic markers, 49 which can be used across multiple traits and diseases, will be the starting point to tailor 50 disease management to the individual. Ultimately, we will be able to capitalise on whole-51 genome sequence and environmental risk factors to realise the full potential of genomic 52 medicine. 53 54 Phenotypic prediction of complex traits from genomic data could transform clinical practice by 55 enabling tailored treatment and targeted disease screening programs based on the genetic 56 make-up of the individual, and by facilitating more efficient allocation of resources within the 57 health systems 5-7 . Ultimately, it would help to understand the underlying disease mechanisms 58 and open the targeted search of specific solutions based on this knowledge. With this in mind, 59 large efforts and investments in the past years have been directed towards generating 60 genotypic and phenotypic data for identifying individual genetic variants associated with 61 different traits through genome-wide association studies (GWAS) 8 . Although using this 62 approach a large number of susceptibility variants for many diseases have been identified, the 63 strategy has several limitations. First, the accuracy of prediction has been disappointingly low 64 for traits affected by a large numbers of susceptibility variants 7 . Second, the approach of 65 identifying one single nucleotide polymorphism (SNP) at a time and including such newly 66
identified SNPs in the prediction models as and when they are identified is unpractical if one 67 wishes to use genetic tests for multiple traits because the composition of each trait's genetic 68 test would need to be continuously updated and each trait would require its own SNP panel. 69
Third, statistical considerations and simulation studies have shown that the accuracy of 70 prediction for complex traits increases by modelling all available SNPs simultaneously 9 . 71
72
Recent studies have shown that SNP arrays containing common genetic variants capture a 73 substantial amount of the genetic variation for each trait and that the contributing SNPs have 74 effects generally too small to be detected with current GWAS sample sizes due to the stringent 75 genome-wide significance levels applied 3,10,11 . Furthermore, we have previously shown 76 through simulations that the size of the studies that have estimated heritability from SNP 77 arrays have been too small to properly estimate SNP effects for accurate phenotypic 78 prediction 12 . However, the availability of large genotyped cohorts for which individual-level 79 data is available, e.g. the UK Biobank 4,13 , combined with new and powerful computational 80 tools 12 capable of fitting complex statistical models to big datasets and access to high-81
performance computational infrastructure has the potential to provide accurate SNP effects 82 for genomic prediction. 83
We show that modelling individual-level data of circa 120,000 individuals can lead to accurate 85 predictions across multiple traits by jointly fitting the SNPs of a single array of common SNPs. 86
These predictions significantly improve on the accuracies of models derived from summary 87 statistics obtained from large GWAS meta-analyses and in turn would ease clinical 88 implementation and direct-to-consumer genetic testing, as well as improve the accuracy of the 89 predictions as the sample sizes of the training datasets increase. 90
91
We first focused on human height, a highly heritable quantitative trait commonly used as a 92 model in the study of the genetic architecture of complex traits 3,10,14 and one of the traits for 93 which most contributing loci have been identified to date. To increase the generality of our 94 findings, we then selected four obesity related traits -BMI, percentage body fat, waist-to-hip 95 ratio (WHR) and basal metabolic rate (BMR). In order to jointly estimate the additive effects of 96 all SNPs we fitted them as random effects in a Mixed Linear Model (MLM) on the training 97 population, with gender and age as fixed effects (Online Methods). As the computational 98 requirements of MLM fitting rapidly increases with incrementing sample sizes, we used 99 DISSECT 12 (https://www.dissect.ed.ac.uk), a software specifically designed to perform 100 genomic analysis in large supercomputers. Each analysis required ~1h of computing time on 101 the ARCHER supercomputer, harnessing the joint power of 1,152 processors. Using the 102 estimated SNP effects to predict the genetic value of individuals in an independent validation 103 dataset (Online Methods), we computed the prediction accuracy as the correlation between 104 these predicted genetic values and the phenotypes corrected for gender and age. 105
For our analyses, we used the 152,736 genotyped individuals available from the UK Biobank 106 cohort 4 . After applying stringent quality control criteria, we divided our sample into White-107
British (123,847 individuals) and non White-British (27,685 individuals), the latter including 108 individuals from different ethnic backgrounds (Online Methods and Supplementary Fig. 1 ). We 109 divided the White-British further into a group of 114,264 unrelated individuals with a 110 relatedness below 0.0625 (i.e. less related to each other than second cousins once removed), 111 another group of 9,583 individuals that had at least one relationship above 0.0625 with the 112 unrelated White-British group, and a group of self-reported White-British (Online Methods and 113 Supplementary Fig. 1 ). We modelled 319,038 common SNPs, that is, variants with a minor 114 allele frequency (MAF) >0.05 that passed our genotype quality control. 115
We used the 114,264 unrelated White-British individuals to train the prediction models and 116 assessed the validity of the within-population predictions using the 9,583 related White-British 117 individuals and the 12,640 self-reported White-British individuals. Prediction accuracy in the 118 self-ported White-British ranged from 0.51 (95% CI 0.49-0.52) for height to 0.20 (95% CI 0.19-119 0.22) for WHR (Table 1) . We evaluated whether prediction accuracies can be further improved 120 by using more complex models (Online Methods). The accuracy for height improved to 0.55 121 (95% CI 0.53-0.56) despite small reduction in the estimate of heritability. However, accuracies 122
for the other traits decreased. The accuracies we obtained represent between 75% and 46% 123 of the maximum achievable given the estimated SNP-based heritabilities of the traits in 124 We also investigated to what extend across-population predictions were feasible. To this end, 132
we further subdivided the non White-British subset by self-reported ethnic background. 133
Excluding ethnicities with less than 1,000 individuals and removing outliers resulted in 7,541 134
White individuals who did not self-report as White-British, 1,954 Asian or Asian-British 135 individuals, and 1,591 Black or Black-British individuals (Online Methods). Predictions 136 obtained in the White cohort (Table 2) were almost as accurate as to those obtained in the 137 self-reported White-British cohort. Predictions for the other two ethnicities remained considerable but lower than within-population predictions, especially for Black or Black British 139 as expected from the genetic distance between populations ( Supplementary Fig. 2) , indicating 140 that predictions may benefit from within-ethnic group tailored models. 141
Although samples sizes for training the models will increase in the future, it is unlikely that they 142 will increase indefinitely. Therefore, we argued that it would be useful to know what sample 143 size would be required to exploit all the genetic variation captured by the SNP array. To gauge 144 that, we computed prediction accuracies for samples of decreasing size, by randomly 145 subsampling the unrelated White-British individuals (Online Methods). Our data fitted very well 146 to a well-known theoretical model 16 . Our predictions suggest that prediction accuracies for 147 height will reach 0.6 (SE = 0.02) when training the models using ~500,000 individuals ( Fig. 1) , 148
the samples planned to be genotyped UK Biobank in the near future. This prediction accuracy 149 would represent 82% of the maximum accuracy possible given the explained heritability. 150
Similarly, we estimate that genetic prediction models for BMI, WHR, body fat percentage and 151 BMR will reach prediction accuracies of 0.36 (SE = 0.05), 0.29 (SE = 0.03), 0.37 (SE = 0.03), 152 and 0.42 (SE = 0.03) respectively ( Supplementary Fig. 3) . 153
Our results confirm previous findings that many variants with small effect can explain a large 154 proportion of the genetic variance. Due to several factors, this part of the genetic variance has 155 so far remained largely unexploited for phenotypic prediction. These factors include the 156 statistical methods used, the available sample sizes, and computational software available to 157 analyse the data. However, as we have shown, predictions which are significantly more 158 accurate can be obtained by increasing sample sizes and using powerful computational 159 approaches to jointly estimate all SNP effects. The phenotypic variance explained by our 160 predictor for height is ~75% larger than that of the largest height meta-analysis to date, which 161 used a discovery sample size ~250% larger than ours, but that used genome-wide significant 162
SNPs from the meta-analyses as predictors 3 . Our prediction accuracies are very close to the 163 maximum achievable given the estimates of the corresponding explained heritable 164 components, and we predict that they will become even closer when the number of samples increase (e.g. when the UK Biobank is fully genotyped). For BMI, which is affected by a smaller 166 genetic component, our predictor explains slightly more variance than previous work that used 167 a discovery sample size ~3 times larger 17 . Finally, we demonstrated that more complex models 168
have the potential to further improve prediction accuracies, although our results also indicate 169 that the optimal model may be trait specific. In conclusion, the presented results support our 170 initial hypothesis and suggest a promising future for genomic prediction of complex traits. As we did with White-British individuals, we only retained those individuals whose projections 201 onto the leading twenty genomic principal components fell within three standard deviations of 202 the ethnicity group mean ( Supplementary Fig. 2) . 203
Phenotype quality control 204
We defined outliers as males and females that were outside ±3 standard deviations from their 205 gender mean of all the individuals in the UK Biobank, and removed them from the analyses. 206
Software 207
The genotype quality control and data filtering was performed using plink 18 (https://www.cog-208 genomics.org/plink2). The PCA, MLMs fittings for estimating SNP effects and phenotype 209 predictions were performed using DISSECT (https://www.dissect.ed.ac.uk) on the UK National 210 Supercomputer (ARCHER). DISSECT software is designed to perform genomic analyses on 211 very large sample sizes without the need to perform mathematical approximations by using 212 the power of large supercomputers. 213
Phenotype prediction 214
The effect of all SNPs were estimated together as a random effect using the model, 215
where is the mean term and the residual for individual . is the number of fixed effects, 217 being the value for the fixed effect at individual and the estimated effect of the fixed 218 effect . is the number of markers and is the standardised genotype of individual at 219 marker . The vector of random SNP effects is distributed as N(0, 2 ). The vector of 220 environmental effects is distributed as N(0, 2 ) . The heritabilities were estimated as 221 2 /( 2 + 2 ). 222
The prediction of the phenotype ̂ for the individual was computed as a sum of the product 223 of the SNP effects and the number of reference alleles of the corresponding SNPs: 224
Where is the number of copies of the reference allele at SNP of individual , is the 226 number of SNPs used for the prediction, and the effect of SNP . * and * are the mean 227 and the standard deviation of the reference allele in the training population. 228
Prediction accuracies were computed as the correlation between the predicted phenotype and 229 the real one after correcting by the estimated effect of the used covariates (e.g. sex and age). 230
Phenotype prediction using a two variance components model 231
The MLM of the previous section assumes that all SNP effects follow a Gaussian distribution 232 with one variance. However this is may not be true. To improve the model we first fitted all 233
SNPs independently using a standard GWAS model, 234
Here, the parameters are the same as in the previous MLM, and the SNP effect size * is 236 estimated independently for each SNP as a fixed effect. We then divided the SNPs into two 237 groups based on their effect size. Specifically, one group of SNPs in the main distribution and 238 a group of outliers, which were defined as SNPs with effect sizes more than 3 standard 239 deviations away from the mean effect across all SNPs. Using these groups, we fit an extended 240 MLM where we assume the SNP effects were distributed in two different Gaussian 241 distributions with a different variance each one, 242
where all parameters are the same as in the simpler MLM, but now M and K are the number 244 of SNPs in the main distribution and the two tails, respectively, while and are the 245 corresponding genotypes. We fit independent variances for the two groups of SNPs, so that 246 the vector of SNP effects in the main distribution, , is distributed as N(0, ( ) 2 ) and the 247 vector of SNP effects in the tails, , is distributed as N(0, ( ) 2 ). 248 249 Random subsampling 250 We computed accuracies for samples of decreasing size, by randomly subsampling 5 of the 251 10-fold cross-validation subsets used in the within unrelated White-British population 252 predictions ( Supplementary Table 1 
